SARGRAMOSTIM for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where SARGRAMOSTIM was used for Bladder cancer.
Most Reported Side Effects for SARGRAMOSTIM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 98 | 16.5% | 12 | 10 |
| Pyrexia | 76 | 12.8% | 3 | 23 |
| Pain | 56 | 9.4% | 2 | 1 |
| Hospitalisation | 31 | 5.2% | 0 | 24 |
| Death | 30 | 5.1% | 29 | 0 |
| Hypotension | 25 | 4.2% | 3 | 18 |
| Device related infection | 23 | 3.9% | 1 | 1 |
| Cough | 20 | 3.4% | 1 | 4 |
| Febrile neutropenia | 20 | 3.4% | 1 | 5 |
| Disease progression | 18 | 3.0% | 9 | 1 |
| Device related bacteraemia | 17 | 2.9% | 0 | 0 |
| Fatigue | 16 | 2.7% | 1 | 8 |
| Hypersensitivity | 16 | 2.7% | 0 | 4 |
| Nausea | 16 | 2.7% | 3 | 2 |
| Injection site erythema | 14 | 2.4% | 0 | 0 |
Other Indications for SARGRAMOSTIM
Neuroblastoma (88)
Product used for unknown indication (48)
Alveolar proteinosis (44)
Pancreatic carcinoma (40)
Pancreatic carcinoma metastatic (39)
Neutropenia (35)
Adrenal gland cancer (26)
Malignant melanoma (24)
Prostate cancer (17)
Neoplasm malignant (12)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)